Source:http://linkedlifedata.com/resource/pubmed/id/10084300
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1999-4-13
|
pubmed:abstractText |
Photodynamic therapy (PDT) is the combination of a photosensitizing drug (Ps) with light in the presence of oxygen leading to the generation of reactive molecular species and destruction of cancer cells. In this study we compared PDT with two Ps, the hematoporphyrin derivative Photosan (Ph) and delta-aminolevulinic acid (ALA)-induced endogenous protoporphyrin IX, with respect to mitochondrial function and ultrastructural alterations. The effects of PDT were investigated in PAM 212 cells after different Ps incubation times, light doses, and post-treatment periods. Both Ps induced a light dose-dependent impairment of the mitochondrial function with the dose-response curve being steep for ALA and flat for Ph. The prolongation of the incubation time from 4 to 20 h resulted in an increased reduction of mitochondrial activity after ALA PDT but not after Ph PDT. Treatment with an irradiation dose that decreased mitochondrial activity by 50% (IC50) led to early and profound changes of mitochondrial morphology in ALA photosensitized cells, whereas photosensitization with Ph resulted in more pronounced alterations of lysosomes. We conclude that at bioequivalent sublethal PDT exposures of PAM 212 cells, ALA-induced damage is primarily restricted to mitochondria, whereas Ph-induced cytotoxicity is mediated by damage of the lysosomal system.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aminolevulinic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Hematoporphyrins,
http://linkedlifedata.com/resource/pubmed/chemical/Photosensitizing Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Porphyrins,
http://linkedlifedata.com/resource/pubmed/chemical/photosan III
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0022-202X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
112
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
264-70
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10084300-Aminolevulinic Acid,
pubmed-meshheading:10084300-Animals,
pubmed-meshheading:10084300-Dose-Response Relationship, Drug,
pubmed-meshheading:10084300-Hematoporphyrins,
pubmed-meshheading:10084300-Keratinocytes,
pubmed-meshheading:10084300-Lysosomes,
pubmed-meshheading:10084300-Mice,
pubmed-meshheading:10084300-Mitochondria,
pubmed-meshheading:10084300-Photochemotherapy,
pubmed-meshheading:10084300-Photosensitizing Agents,
pubmed-meshheading:10084300-Porphyrins,
pubmed-meshheading:10084300-Time Factors,
pubmed-meshheading:10084300-Tumor Cells, Cultured
|
pubmed:year |
1999
|
pubmed:articleTitle |
Ultrastructural changes in PAM cells after photodynamic treatment with delta-aminolevulinic acid-induced porphyrins or photosan.
|
pubmed:affiliation |
Division of Special and Environmental Dermatology, University of Vienna, Austria.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|